Tag: neuroleptic malignant syndrome
Letter to the Editor: Beware of Neuroleptic Malignant Syndrome in COVID-19 Pandemic
Dear Editor: I read with great interest the recent article by Buttar et al1 detailing fatal consequences of the chronic neuroleptic malignant syndrome (NMS) from the United States. The authors prescribed the challenges of treating psychiatric patients with the possibility of NMS. They also indicated that ethnic groups concerning metabolic enzyme polymorphisms for antipsychotics, such […]
The Problem of Atypical Neuroleptic Malignant Syndrome: A Case Report
by Brendan T. Carroll, MD, and Susan A. Surber, Pharm.d Dr. Carroll is Associate Professor of Psychiatry (Volunteer), University of Cincinnati, College of Medicine, and Chief, Psychiatry Service, MHCL, Chillicothe VAMC, Chillicothe, OH; Dr. Surber is of the Cleveland Clinic Foundation, Cleveland, OH.
